| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 03/18/2003 | US6534506 Inhibitors of prenyl-protein transferase |
| 03/18/2003 | US6534491 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 03/13/2003 | US20030050300 Therapeutic 5-HT ligand compounds |
| 03/12/2003 | EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 03/12/2003 | EP0672031B1 Catechol diethers as selective pde iv inhibitors |
| 03/12/2003 | CN1402730A Thiazolo (4,5-D) pyrimidine compounds |
| 03/12/2003 | CN1402727A Bicyclic imidazo-3-yl-amine derivs. which are substd. on sixth ring |
| 03/12/2003 | CN1402726A Bicyclic imidazo-5-yl-amine derivs. |
| 03/11/2003 | US6531487 Water solubility; bioavailability |
| 03/11/2003 | US6531484 Viricides for preventing infection by HIV, treating infection by HIV, delaying of the onset of AIDS, or treating AIDS |
| 03/07/2003 | WO2002020531A2 Method for producing anellated tetrahydro-[1h]-triazoles |
| 03/07/2003 | CA2421839A1 Method for producing anellated tetrahydro-[1h]-triazoles |
| 03/06/2003 | WO2003018587A1 Helix mimetics and composition and methods related thereto |
| 03/06/2003 | WO2002055507A8 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors |
| 03/06/2003 | US20030045545 Immunomodulators, induce cytokine biosynthesis, and antineoplastic agents |
| 03/05/2003 | EP1287002A1 Crf receptor antagonists |
| 03/05/2003 | EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 03/05/2003 | EP0690863B1 Tetracyclic compounds as dopamine agonists |
| 03/05/2003 | CN1400973A Novel biarylcarboxamides |
| 03/05/2003 | CN1102596C 5H-thiazole [3,2-a] pyrmidine derivatives |
| 03/05/2003 | CN1102595C Penems and their derivatives |
| 03/05/2003 | CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003016248A2 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) |
| 02/27/2003 | WO2003016245A1 Chromatographic separation of enantiomers of protected amino acids via smb-method |
| 02/27/2003 | WO2003015773A2 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002028865A3 Condensed pyridoindole derivatives |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/26/2003 | CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 02/25/2003 | US6525070 Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists |
| 02/25/2003 | US6525047 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair |
| 02/25/2003 | US6525045 Positive allosteric AMPA receptor modulators |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525000 N-aminoureas are reacted with formaldehyde to give methyleneimino ureas, cyclizing these to give tetrahydro-4H-1,3,4-oxa(or thia)diazines, and cyclizing the fused triazoles using phosgene; herbicides |
| 02/20/2003 | WO2003014125A1 Therapeutically useful tetracyclic ligands |
| 02/20/2003 | WO2003014121A1 Compounds, derivatives, compositions, preparation and uses |
| 02/20/2003 | WO2002072585A3 Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/20/2003 | WO2001079187A8 Substituted 1,4-thiazepine and analogs and their use as activators of caspases |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | CA2453219A1 Therapeutically useful tetracyclic ligands |
| 02/19/2003 | EP1283834A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283833A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283832A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/19/2003 | EP1283831A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/13/2003 | WO2003011870A1 Gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011824A1 Bicyclic modulators of androgen receptor function |
| 02/13/2003 | WO2003011286A1 Core modified porphyrins |
| 02/13/2003 | WO2003011222A2 Thrombin inhibitors |
| 02/13/2003 | US20030032652 Hydroxamic and carboxylic acid derivatives |
| 02/13/2003 | US20030032647 Aromatic nitrogen-containing 6-membered cyclic compounds |
| 02/13/2003 | US20030032642 Treating psoriasis, a disease in which angiogenesis is associated with raised CXCR2 chemokine levels, or COPD. |
| 02/12/2003 | EP1282622A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP0828488B1 Isothiazolones |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/11/2003 | US6518423 Benzopiperidine derivatives |
| 02/11/2003 | US6518422 Hydrogenation of 5,5-dioxo-2,3-dihydro-1H-pyrrolo-(2,1-c)(1,2,4)benzothiadiazine with a complex of ruthenium dichloride with 2,2'-bis(diphenylphosphine)-1,1'-binaphthyl and 1,2-diphenylethylenediamine as catalyst |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518268 Telomerase inhibitors and methods of their use |
| 02/11/2003 | CA2030715C Hexahydro-1h-quino¬4,3,2-ef|¬1,4|benzoxazepines and related compounds, a process and intermediates for their preparation and their use as medicaments |
| 02/06/2003 | WO2003010138A2 Piperidine derivatives as antibacterial agents |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/05/2003 | CN1394857A Compound used as antiproliferative agent and glycinamide ribonucleotide transformylase inhibitor |
| 02/04/2003 | US6515170 Enzymatic oxidative deamination process |
| 02/04/2003 | US6515157 Ferrocenyldiphosphine-ruthenium complexes and a hydrogenation process of exocyclic double bond of d-thiophene to d-thiophane |
| 02/04/2003 | US6514972 Heteropolycyclic inhibitors of protein kinases |
| 01/30/2003 | WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | WO2002059129A3 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists |
| 01/30/2003 | US20030022914 Nitric oxide synthase inhibitors |
| 01/30/2003 | US20030022905 Prevention and/or therapy of ischaemia and reperfusion damage; poly(ADP-ribose)-synthetase inhibitors |
| 01/30/2003 | US20030022898 Methods of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK) |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | CA2454007A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/29/2003 | EP1279674A2 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/29/2003 | EP1278744A1 Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors |
| 01/29/2003 | EP1129097B1 Novel type condensed pyridazinone compounds |
| 01/29/2003 | EP1104425B1 Novel thiazolopyrimidine compounds |
| 01/29/2003 | EP0835243B1 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/29/2003 | CN1393449A Thienothiazine compound with anti-inflammatory and antalgic activity and its preparing process and usage |
| 01/28/2003 | US6511977 For preventing or treating cardiac arrhythmia or atrial arrhythmia |
| 01/28/2003 | CA2124375C Compounds containing a fused bicyclic ring and processes therefor |
| 01/23/2003 | WO2003006471A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 01/23/2003 | WO2003006470A2 THIAZOLO [4,5-b]PYRIDINES AS FUNGICIDES |
| 01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | WO2002085915A3 Novel insecticidal azoles |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/23/2003 | WO2002036562A3 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 01/23/2003 | US20030018032 Bicyclic imidazo-3-yl-amine derivatives |
| 01/23/2003 | US20030018022 Antiinflammatory agents; antiallergens |
| 01/23/2003 | CA2453554A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 01/23/2003 | CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/22/2003 | EP1277741A1 Cyclic compounds |
| 01/22/2003 | EP0646115B1 Heterocyclic-cyclic amine derivatives |
| 01/16/2003 | WO2002051837A3 Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/15/2003 | EP1274709A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines |